- Scott Phillips
- Feb 28, 2016
- biotechnology industry organization, G2G Consulting, liz powell, Mark Leahy, MEDC, Medical Device Manufacturers Association, michbio, roger newton, Stephen Rapundalo
Leaders from the bio-industry, academia, and policy realms recently met in Lansing to discuss how to best unleash Michigan’s biosciences R&D and manufacturing potential to stimulate economic growth. The Michigan Bio-Industry Growth Summit was hosted by MichBio.
Stephen Rapundalo, PhD, President and CEO of MichBio reviewed the details of a forward-looking strategy for building a strong, statewide biosciences cluster and what’s needed across key sectors and specialty market areas to leverage the state’s strengths and opportunities – as well as best practices – to enhance competitiveness and develop Michigan into a preeminent biosciences leader! The event was co-sponsored by Doug Rothwell, President and CEO of Business Leaders for Michigan and Jeffrey Mason, Executive Director, University Research Corridor.
Roger Newton, Executive Chairman and CSO, Esperion Therapeutics kicked off the day be moderating a session with Mark Leahey, CEO, Medical Device Mfrs. Assc. (MDMA) and Liz Powell, Principal, G2G Consulting. The group discussed key findings from a recent report entitled “Bioscience Economic Development in the States.” The report compared state level legislative and job creation best practices.
I was quite impressed with the quality of the event. Stephen Rapundalo and his co-organizers had clearly done a magnificent job in terms of preparation. The topics were very relevant and the speakers were all very accomplished and thought leaders on their subjects. Networking before and after the event was particularly valuable. I am already looking forward to attending next year.